Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
102,398,919
-
Total 13F shares
-
300,344
-
Share change
-
+221,640
-
Total reported value
-
$216,624
-
Price per share
-
$0.72
-
Number of holders
-
10
-
Value change
-
+$151,923
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA) as of Q2 2025
As of 30 Jun 2025,
Pasithea Therapeutics Corp. - Common Stock (KTTA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
300,344 shares.
The largest 10 holders included
AdvisorShares Investments LLC, CITADEL ADVISORS LLC, UBS Group AG, LPL Financial LLC, Hurley Capital, LLC, RAYMOND JAMES FINANCIAL INC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., JPMORGAN CHASE & CO, and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.